Skip to main content

Home

  • Home
  • Hot
  • New
  • Opinions
  • Media
    • The Times of Israel
    • The Yeshiva World
    • Voz Iz Neias
    • Matzav
  • Home
  • Early clinical trial for ALS sufferers shows biotech firm ‘on the right track’
03 Oct

Early clinical trial for ALS sufferers shows biotech firm ‘on the right track’

By admin 0 Comments

Israeli company Kadimastem says interim results of first patient group indicate new drug 'managed to significantly slow down disease progression'

Details
Vote up!
Vote down!

Points: -1

Category: 
Startup Israel
Israeli startups
Kadimastem
biotechnology
Amyotrophic Lateral Sclerosis (ALS)
Rami Epstein
Michel Revel
Weizmann Institute of Science
  • Log in or register to post comments

Author

anon

admin

Hot

  • Huckebee: “Israel Is Doing A Lousy Job At Genocide, Even US Doesn’t Warn Civilians Before Striking”
  • U.S. Embassy in Bahrain Denies Changes Amid Iran Tensions, Operations Normal
  • IDF Releases Footage of Israeli Air Force Destroying Iranian Missile Launcher

User login

  • Create new account
  • Request new password

Recent comments

No comments available.